11.07.2015 Views

Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

368 IV. SPECIAL POPULATIONSThe expanding role <strong>of</strong> opioid therapy in the treatment <strong>of</strong> chronic painlends particular urgency to the ne<strong>ed</strong> for an accurate and dispassionate appraisal<strong>of</strong> the benefits and risks associat<strong>ed</strong> with pain control and chemical dependence.M<strong>ed</strong>ical perceptions surrounding opioid therapy have cycl<strong>ed</strong> dramatically duringthe past century (Musto, 1999; Rock, 1977). A more liberal approach toprescribing began during the latter part <strong>of</strong> the 20th century with worldwideendorsement <strong>of</strong> opioid therapy for cancer pain. This spurr<strong>ed</strong> a more gradualacceptance <strong>of</strong> the view that opioid therapy may be appropriate for larger numbers<strong>of</strong> patients with chronic pain. During the past 10 years, this acceptance hasadvanc<strong>ed</strong> throughout the community <strong>of</strong> pain specialists, driven by favorableexperiences with these drugs, incontrovertible evidence <strong>of</strong> widespread undertreatment<strong>of</strong> pain, and the r<strong>ed</strong>uc<strong>ed</strong> stigmatization <strong>of</strong> opioid drugs. From thisperspective, opioid use was encourag<strong>ed</strong>, with relatively little focus on thepotential risks associat<strong>ed</strong> with abuse, addiction, and diversion. Inde<strong>ed</strong>, for somepractitioners, the myth <strong>of</strong> inevitable addiction was replac<strong>ed</strong> by another myth,bas<strong>ed</strong> on the misapprehension that chronic pain patients are somehow “immune”to the problems <strong>of</strong> misuse, abuse, addiction, or diversion (Fri<strong>ed</strong>man,1990).Pain specialists now have begun to realize that the issues relat<strong>ed</strong> to chemicaldependence are central to the safe and effective use <strong>of</strong> opioids as analgesicsfor chronic pain. The emphasis is now on a balanc<strong>ed</strong> perspective, in whichpotential therapeutic benefits are weigh<strong>ed</strong> against this risk. With a balanc<strong>ed</strong>perspective, the divide between pr<strong>of</strong>essionals in addiction m<strong>ed</strong>icine and painm<strong>ed</strong>icine is narrowing, and a new level <strong>of</strong> discourse may enhance the ability <strong>of</strong>each discipline to comprehend clinical phenomena and formulate questions forresearch.DEFINITIONS AND PHENOMENOLOGYR<strong>ed</strong>efining Abuse and AddictionBoth clinical practice and research depend on a valid nomenclature for thephenomena associat<strong>ed</strong> with drug abuse and addiction. Unfortunately, this terminologyhas been problematic historically, and clarification is a necessary firststep in advancing the understanding <strong>of</strong> the relationship between pain andchemical dependence.ToleranceTolerance is a pharmacological property defin<strong>ed</strong> by the ne<strong>ed</strong> for increasingdoses <strong>of</strong> a drug to maintain effects (Dole, 1972; Martin & Jasinski, 1969). Itimplies that exposure to the drug itself is the “driving force” for the physiologi-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!